Skip to content

The study of Low-Pulsed Intensity Ultrasounds (LIPUS) treatment for osteonecrosis of femoral head (ONFH)

The study of Low-Pulsed Intensity Ultrasounds (LIPUS) treatment for osteonecrosis of femoral head (ONFH) - The study of LIPUS treatment for ONFH

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006571
Enrollment
30
Registered
2011-11-01
Start date
2012-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteonecrosis of femoral head

Interventions

To do the LIPUS treatment for ONFH

Sponsors

Department of Orthopaedic Surgery, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences and University Hospital, University of Tsukuba
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: To fulfill both Stage 2 or 3 and type B or C in criteria of diagnosis for ONFH

Exclusion criteria

Exclusion criteria: 1. Serious complications (heart disease, liver disease, kidney disease, etc.) 2. Taking Bisphosphonates or Raloxifene before the date of informed consent 3. A history (or suspection) of malignancy within 5 years before the date of informed consent 4. A suspected pregnancy or during pregnancy 5. An administered study for drug or investigational device within one month of study initiation 6. Not having the ability to accept voluntary 7. Unable to obtain the written informed consent 8. An inadequate case judged by doctor

Design outcomes

Primary

MeasureTime frame
X-ray, Computed Tomography(CT), Magnetic Resonance Imaging(MRI)

Secondary

MeasureTime frame
Clinical findings (pain:Visual Analog Scale(VAS) scoring, range of motion, questionnaire)

Countries

Japan

Contacts

Public ContactHajime Mishima

Graduate School of Comprehensive Human Sciences and University Hospital, University of Tsukuba Department of Orthopaedic Surgery, Institute of Clinical Medicine

hmishima@md.tsukuba.ac.jp029-853-3219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026